|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Cell. 124:1169–1181.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattie MD, Benz CC, Bowers J, Sensinger K,
Wong L, Scott GK, Fedele V, Ginzinger D, Getts R and Haqq C:
Optimized high-throughput microRNA expression profiling provides
novel biomarker assessment of clinical prostate and breast cancer
biopsies. Mol Cancer. 5:242006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Yu J, Wang L, Ding D, Zhang L, Chu
C, Chen Q, Xu Z, Zou Q and Liu X: miR-320a is an independent
prognostic biomarker for invasive breast cancer. Oncol Lett.
8:1043–1050. 2014.PubMed/NCBI
|
|
9
|
Sun JY, Huang Y, Li JP, Zhang X, Wang L,
Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, et al: MicroRNA-320a
suppresses human colon cancer cell proliferation by directly
targeting β-catenin. Biochem Biophys Res Commun. 420:787–792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun L, Liu B, Lin Z, Yao Y, Chen Y, Li Y,
Chen J, Yu D, Tang Z, Wang B, et al: MiR-320a acts as a prognostic
factor and Inhibits metastasis of salivary adenoid cystic carcinoma
by targeting ITGB3. Mol Cancer. 14:962015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P,
Zhang Q, Dong L, Liu Y and Dong J: microRNA-320a inhibits tumor
invasion by targeting neuropilin 1 and is associated with liver
metastasis in colorectal cancer. Oncol Rep. 27:685–694.
2012.PubMed/NCBI
|
|
12
|
Xu G, Wu J, Zhou L, Chen B, Sun Z, Zhao F
and Tao Z: Characterization of the small RNA transcriptomes of
androgen dependent and independent prostate cancer cell line by
deep sequencing. PLoS One. 5:e155192010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui
J, Liu Y, Gao Z, Li J, Shen L and Lu Y: Combination of hsa-miR-375
and hsa-miR-142-5p as a predictor for recurrence risk in gastric
cancer patients following surgical resection. Ann Oncol.
22:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang
Z, Chen F and Zheng G: Identification of hsa-miR-335 as a
prognostic signature in gastric cancer. PLoS One. 7:e400372012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Q, Dong QG, Sun LP, He CY and Yuan Y:
Expression of serum miR-20a-5p, let-7a, and miR-320a and their
correlations with pepsinogen in atrophic gastritis and gastric
cancer: A case-control study. BMC Clin Pathol. 13:112013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stenmark H: Rab GTPases as coordinators of
vesicle traffic. Nat Rev Mol Cell Biol. 10:513–525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reiner DJ and Lundquist EA: Small GTPases.
WormBook. 1–99. 2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang R, Wang ZX, Yang JS, Pan X, De W and
Chen LB: MicroRNA-451 functions as a tumor suppressor in human
non-small cell lung cancer by targeting ras-related protein 14
(RAB14). Oncogene. 30:2644–2658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun J, Feng X, Gao S and Xiao Z:
microRNA-338-3p functions as a tumor suppressor in human
non-small-cell lung carcinoma and targets Ras-related protein 14.
Mol Med Rep. 11:1400–1406. 2015.PubMed/NCBI
|
|
20
|
Li L, Luo J, Wang B, Wang D, Xie X, Yuan
L, Guo J, Xi S, Gao J, Lin X, et al: Microrna-124 targets
flotillin-1 to regulate proliferation and migration in breast
cancer. Mol Cancer. 12:1632013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang SZ, Pan FY, Xu JF, Yuan J, Guo SY,
Dai G, Xue B, Shen WG, Wen CJ, Zhao DH and Li CJ: Knockdown of
c-Met by adenovirus-delivered small interfering RNA inhibits
hepatocellular carcinoma growth in vitro and in vivo. Mol Cancer
Ther. 4:1577–1584. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang F, Sarangarajan R, Le Poole IC,
Medrano EE and Boissy RE: The cytotoxicity and apoptosis induced by
4-tertiary butylphenol in human melanocytes are independent of
tyrosinase activity. J Invest Dermatol. 114:157–164. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang SH, Wang CJ, Shi L, Li XH, Zhou J,
Song LB and Liao WT: High expression of FLOT1 is associated with
progression and poor prognosis in hepatocellular carcinoma. PLoS
One. 8:e647092013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lian S, Park JS, Xia Y, Nguyen TT, Joo YE,
Kim KK, Kim HK and Jung YD: MicroRNA-375 functions as a
tumor-suppressor gene in gastric cancer by targeting recepteur
d'origine nantais. Int J Mol Sci. 17:pii: E1633. 2016. View Article : Google Scholar
|
|
25
|
Gui J, Tian Y, Wen X, Zhang W, Zhang P,
Gao J, Run W, Tian L, Jia X and Gao Y: Serum microRNA
characterization identifies miR-885-5p as a potential marker for
detecting liver pathologies. Clin Sci (Lond). 120:183–193. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu M, Zhang N, He S, Yan R and Zhang J:
MicroRNA-106a functions as an oncogene in human gastric cancer and
contributes to proliferation and metastasis in vitro and in vivo.
Clin Exp Metastasis. 33:509–519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang HH, Wang XJ, Li GX, Yang E and Yang
NM: Detection of let-7a microRNA by real-time PCR in gastric
carcinoma. World J Gastroenterol. 13:2883–2888. 2007.PubMed/NCBI
|
|
29
|
Yang Q, Jie Z, Cao H, Greenlee AR, Yang C,
Zou F and Jiang Y: Lowlevel expression of let-7a in gastric cancer
and its involvement in tumorigenesis by targeting RAB40C.
Carcinogenesis. 32:713–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C,
Quan L, Bai J and Xu N: miR-106a is frequently upregulated in
gastric cancer and inhibits the extrinsic apoptotic pathway by
targeting FAS. Mol Carcinog. 52:634–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026.
2012.PubMed/NCBI
|
|
32
|
Zhang D, Xiao YF, Zhang JW, Xie R, Hu CJ,
Tang B, Wang SM, Wu YY, Hao NB and Yang SM: miR-1182 attenuates
gastric cancer proliferation and metastasis by targeting the open
reading frame of hTERT. Cancer Lett. 360:151–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takai Y, Sasaki T and Matozaki T: Small
GTP-binding proteins. Physiol Rev. 81:153–208. 2001.PubMed/NCBI
|
|
34
|
Agarwal R, Jurisica I, Mills GB and Cheng
KW: The emerging role of the RAB25 small GTPase in cancer. Traffic.
10:1561–1568. 2009. View Article : Google Scholar : PubMed/NCBI
|
